Sees FY25 revenue $2.8B-$2.85B, consensus $2.86B.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVTY:
- RVTY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Revvity price target lowered to $140 from $146 at Raymond James
- Early notable gainers among liquid option names on January 13th
- Revvity, Element Biosciences collaborate to commercialize IVD solution
- Revvity to Announce Q4 and Full-Year 2024 Results